News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • iQIYI released the trailer for its first full-length hybrid AI drama 'Immortals Over Mortal Love', using NadouPro to cut production costs and premiering Q4 2026.
  • China's semiconductor equipment imports rose to $4.76 billion in August, up 16% year-over-year, reversing a long downtrend.
  • Front-end processing tools drove the August gains while parts imports declined, indicating fab-equipment demand outpaced component purchases.
  • Japan remained China's largest supplier despite declines, Singapore shipments grew, and U.S.-origin equipment slipped amid apparent rerouting.
  • Nordic American Tankers said freight rates and steady tanker demand remain exceptionally strong, supporting vessel earnings and cash flow.

Latest Articles

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant

Autonomix Medical, a U.S.-based medical device company specializing in precision nerve-targeted treatments, announced the grant of a Canadian patent for its endoscopic sympathectomy systems and methods. This latest patent, part of a broader IP portfolio including U.S. and European patents, covers real-time nerve sensing, mapping, and closed-loop ne…

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit

Cognition Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq as CGTX, announced that CEO Lisa Ricciardi will participate in a fireside chat at the B. Riley Mind, Muscle & Vision Summit to discuss the company's ongoing START Phase 2 study and plans for initiating a Phase 3 registrational trial of their lead candidate, zervimes…

Seagate Shares Weaken as Middle East Tensions Spur Broad Chip Selloff

Seagate Shares Weaken as Middle East Tensions Spur Broad Chip Selloff

Seagate Technology plunged in pre-market trading as a renewed confrontation between the United States and Iran over the weekend pushed oil prices higher and sparked a global risk-off move that hit technology and semiconductor equities. The stock’s recent elevated valuation after a strong year-to-date rally amplified its sensitivity to the sector-wi…

Lazard: U.S. Natural Gas Power Costs Reach Highest Level in at Least 17 Years

Lazard: U.S. Natural Gas Power Costs Reach Highest Level in at Least 17 Years

The levelized cost of electricity (LCOE) for combined-cycle natural gas plants in the United States rose to $90 per megawatt-hour in 2026, the highest reported since at least 2009, Lazard Inc. said. Lazard also reported double-digit increases in solar and onshore wind LCOEs, and noted that growth in demand from new data centers is expected to push …

Saia Shares Climb After BofA Upgrades Stock, Raises Price Target

Saia Shares Climb After BofA Upgrades Stock, Raises Price Target

Saia Inc. shares rose 3.7% after BofA Securities upgraded the stock to Buy from Neutral and nudged its price target to $502 from $499. Analyst Ken Hoexter pointed to improving demand readings from BofA's Truck Shipper Survey, opportunities to raise service, productivity and yield at the less-than-truckload carrier, and a valuation discount versus t…

Trump Shifts Crypto Proceeds into Stocks and Bonds, Disclosures Show

Trump Shifts Crypto Proceeds into Stocks and Bonds, Disclosures Show

New financial disclosures indicate that President Donald Trump received over $1.4 billion last year from crypto ventures tied to his family and shifted a substantial share of those proceeds into portfolios of stocks and bonds. The filings show marked increases in traditional asset ranges by the end of 2025, continued holdings of World Liberty Finan…

Niel's Vega Strengthens Hold on Vodafone as Shares Extend Rally

Niel's Vega Strengthens Hold on Vodafone as Shares Extend Rally

Vodafone shares climbed again after Xavier Niel’s family vehicle, Vega, agreed to buy e& Group’s entire 16.2% stake in the telecoms group. The deal makes Vega the largest shareholder, values the stake at roughly $5.95 billion and includes cash plus an upcoming dividend; analysts describe the move as broadly positive but say uncertainty remains over…

Brazil’s Coffee Crop Faces El Niño Pressure but Shows Greater Resilience

Brazil’s Coffee Crop Faces El Niño Pressure but Shows Greater Resilience

Brazil’s forecast record coffee output of 66.7 million 60-kg bags faces the risk of a significant reduction as El Niño-driven heat and uneven rainfall threaten yields and quality. The Brazilian Coffee Industry Association (Abic) says production could fall 15% to 20%, yet industry representatives note advances in irrigation and crop technology have …

Stocks Edge Higher Ahead of Key Inflation Readings and Bank Earnings

Stocks Edge Higher Ahead of Key Inflation Readings and Bank Earnings

U.S. equities finished the week modestly higher, powered by gains in several large technology names. The S&P 500 and Nasdaq posted weekly advances while the Dow lagged slightly. Investors now shift focus to a packed macro and corporate calendar, including June CPI, PPI, retail sales and a slate of major bank results that will formally open second-q…

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

Longeveron Inc. announced new analyses from its Phase 2a trial of laromestrocel, a stem cell therapy for mild Alzheimer's disease, revealing significant reduction in neuroinflammation and brain atrophy as measured by free water MRI. The therapy showed correlations with improved clinical outcomes and blood biomarker changes. Laromestrocel has FDA RM…

Q32 Bio Shares Jump After Positive 36-Week Results for Alopecia Areata Drug

Q32 Bio Shares Jump After Positive 36-Week Results for Alopecia Areata Drug

Q32 Bio Inc. (NASDAQ:QTTB) stock climbed 60% after the company released positive 36-week topline results from Part B of its SIGNAL-AA Phase 2a study of bempikibart in patients with severe or very severe alopecia areata. The trial met its primary endpoint, showing a 35.3% mean reduction in SALT score in the prespecified modified intent-to-treat anal…

Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa

Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa

Ocugen, Inc. announced a binding term sheet with Roots Pharmaceutical and Al-Dhow International Holding for the exclusive rights to develop and commercialize OCU400, a modifier gene therapy for Retinitis Pigmentosa, in the Middle East and North Africa. The deal includes up to $4 million in upfront and near-term development payments, potential $255 …

CoreCivic to Redeem 4.750% Senior Notes Due 2027

CoreCivic to Redeem 4.750% Senior Notes Due 2027

CoreCivic, a leading government-solutions company, has declared its intention to redeem in full its outstanding $250 million 4.750% senior notes due in 2027 on August 12, 2026. The redemption will be funded using cash on hand at a price including principal, a make-whole premium, and accrued interest. This action reflects CoreCivic's management of i…

Plug Power Announces Sale of Graham, Texas Project and Staged Closing of New York Gateway Project with Stream Data Centers, Expects $80 Million in Near-Term Liquidity as Part of $275 Million-Plus Initiative

Plug Power Announces Sale of Graham, Texas Project and Staged Closing of New York Gateway Project with Stream Data Centers, Expects $80 Million in Near-Term Liquidity as Part of $275 Million-Plus Initiative

Plug Power announced two transactions with Stream Data Centers involving the sale of its Graham, Texas Project and a staged closing of its New York Gateway Project. These deals are part of Plug Power's broader strategic initiative aimed at improving liquidity by over $275 million through asset monetization, cash collateral release, and maintenance …